Porto-sinusoidal vascular disease: proposal and description of a novel entity.


Journal

The lancet. Gastroenterology & hepatology
ISSN: 2468-1253
Titre abrégé: Lancet Gastroenterol Hepatol
Pays: Netherlands
ID NLM: 101690683

Informations de publication

Date de publication:
05 2019
Historique:
received: 05 12 2018
revised: 16 01 2019
accepted: 17 01 2019
entrez: 9 4 2019
pubmed: 9 4 2019
medline: 3 6 2020
Statut: ppublish

Résumé

Portal hypertension in the absence of portal vein thrombosis and without cirrhosis, but with mild or moderate alterations of liver histology (eg, obliterative venopathy, nodular regenerative hyperplasia, or incomplete septal cirrhosis) is being increasingly recognised. Owing to the heterogeneity of causes and histological findings, a substantial number of terms have been used to describe such idiopathic non-cirrhotic portal hypertension. Patients with the same clinical and histological features exist, but without portal hypertension at the time of diagnosis. Therefore, improved criteria are needed to define this form of liver disease. Here, we propose the term porto-sinusoidal vascular disease, since all lesions found involve the portal venules or sinusoids. The definition of this entity is based on the characteristic absence of cirrhosis with or without signs of portal hypertension or histological lesions. The presence of known causes of liver disease does not rule out porto-sinusoidal vascular disease, but specific causes of vascular liver disease are excluded from its definition. The diagnosis of porto-sinusoidal vascular disease is based on liver biopsy and might include signs specific for portal hypertension with normal or mildly elevated liver stiffness values and no complete portal vein thrombosis. We provide simple diagnostic criteria, because agreement on a uniform nomenclature is an essential requirement for future collaborative studies.

Identifiants

pubmed: 30957754
pii: S2468-1253(19)30047-0
doi: 10.1016/S2468-1253(19)30047-0
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-411

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Andrea De Gottardi (A)

University Clinic for Visceral Surgery and Medicine, Inselspital, Bern, Switzerland; Department of Biomedical Research, University of Bern, Bern, Switzerland.

Pierre-Emmanuel Rautou (PE)

Service d'Hépatologie, Hôpital Beaujon, Clichy, France; Centre de Recherche de l'Inflammation, Inserm and Université Paris Diderot, Paris, France.

Jeoffrey Schouten (J)

Ghent University Hospital, Ghent, Belgium.

Laura Rubbia-Brandt (L)

Service de Pathologie Clinique, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Frank Leebeek (F)

Department of Haematology, Erasmus University Medical Center, Rotterdam, Netherlands.

Jonel Trebicka (J)

Department of Internal Medicine I, University of Bonn, Bonn, Germany; European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.

Sarwa Darwish Murad (SD)

Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.

Valérie Vilgrain (V)

Service de Radiologie, Hôpital Beaujon, Clichy, France.

Virginia Hernandez-Gea (V)

Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain; CIBER Hepatic and Digestive Diseases, Instituto de Salud Carlos III, Madrid, Spain.

Filipe Nery (F)

Centro Hospitalar Universitário and EpiUnit, Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.

Aurélie Plessier (A)

Service d'Hépatologie, Hôpital Beaujon, Clichy, France; Centre de Recherche de l'Inflammation, Inserm and Université Paris Diderot, Paris, France.

Annalisa Berzigotti (A)

University Clinic for Visceral Surgery and Medicine, Inselspital, Bern, Switzerland; Department of Biomedical Research, University of Bern, Bern, Switzerland.

Paulette Bioulac-Sage (P)

Inserm U1053, Université de Bordeaux, Bordeaux, France.

Massimo Primignani (M)

Gastroenterologia ed Epatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

David Semela (D)

Gastroenterology and Hepatology, Kantonsspital, St Gallen, Switzerland.

Laure Elkrief (L)

Hepatology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Pierre Bedossa (P)

School of Medicine, Hôpital Beaujon, Clichy, France.

Dominique Valla (D)

Service d'Hépatologie, Hôpital Beaujon, Clichy, France; Centre de Recherche de l'Inflammation, Inserm and Université Paris Diderot, Paris, France.

Juan Carlos Garcia-Pagan (JC)

Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain; CIBER Hepatic and Digestive Diseases, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jcgarcia@clinic.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH